'A special day': End of Pfizer trial paves way for a COVID shot this year
Final results from Pfizer Inc's COVID-19 vaccine trial showed its shot had a 95% success rate and two months of safety data, paving the way for the drugmaker to apply for an emergency U.S. authorization within days, it said on Wednesday. Soraya Ali reports.
UP NEXT
NOW PLAYING: other
'A special day': End of Pfizer trial paves way for a COVID shot this year
Reuters
UP NEXT
-
Australia's Qantas Airways lowers domestic capacity forecast for March quarter
Reuters
-
Look, up in the sky - it's a flying Cadillac! GM unveils futuristic vehicle
-
For many, COVID-19 has changed the world of work for good
-
Apple, Hyundai set to agree electric car tie-up, says Korea IT News
-
Boeing to pay $2.5 billion to settle U.S. criminal probe into 737 MAX crashes
-
Shares soar to record highs on global recovery hopes
-
Elon Musk leaves behind Amazon's Bezos to become world's richest person - Bloomberg News
-
Bonds slip, stocks climb after Democrats win Senate
-
Bitcoin emergence as 'digital gold' could lift price to $146,000, says JPM
-
Factories bounce back from COVID-19 hit, tighter controls cloud outlook
-
Oil set for 20% drop in 2020 as lockdowns weigh, market eyes stimulus
-
Bitcoin hits record $28,600 as 2020 rally powers on
-
Stocks dip as U.S. stimulus underwhelms and coronavirus angst lingers
-
Hackers' broad attack sets cyber experts worldwide scrambling to defend networks
-
Sony outlaws Cyberpunk from PlayStation Store after bug backlash
-
Microsoft says it found malicious software in its systems
![image beacon](https://web.vortex.data.msn.com/collect/v1/t.gif?name=%27Ms.Webi.PageView%27&ver=%272.1%27&appId=%27JS%3AMSN%27&ext-app-env=%27prod%27&ext-javascript-libver=%274.0.0-beta-10%27&ext-user-localId=%27t%3A3A9A74E109AA65DD3DDF7B21081D642F%27&*baseType=%27Ms.Content.PageView%27&*isJs=False&*title=%27%27&*isLoggedIn=False&*isManual=True&*serverImpressionGuid=%279aa869b7-ce05-4c7d-aa87-b3b37321a71f%27&-ver=%271.0%27&-impressionGuid=%279aa869b7-ce05-4c7d-aa87-b3b37321a71f%27&-pageName=%27channelplayerpage%27&-uri=%27https%253A%252F%252Fwww.msn.com%252Fen-au%252Fmoney%252Fother%252Fa-special-day-end-of-pfizer-trial-paves-way-for-a-covid-shot-this-year%252Fvp-BB1b8GfR%27&-referrerUri=%27%27&-pageTags=%27{"pg.t"%3A"video"%2C"pg.p"%3A"prime"%2C"pg.c"%3A""%2C"ex"%3A""%2C"rid"%3A"9aa869b7ce054c7daa87b3b37321a71f"%2C"clid"%3A"3A9A74E109AA65DD3DDF7B21081D642F"%2C"clidType"%3A"muid"%2C"di"%3A"19553"%2C"partner"%3A"Reuters"%2C"publcat"%3A"Reuters%2BNews%2B%2526%2BMedia%2BInc."%2C"cvs"%3A"Browser"%2C"subcvs"%3A"finance"%2C"entityId"%3A"BB1b8GfR"%2C"entitySrc"%3A"vp"%2C"provid"%3A"AAf3a78"%2C"dpt"%3A"other"%2C"sdpt"%3A""%2C"ar"%3A"0"%2C"dgk"%3A"downlevel.pc"%2C"imd"%3A"0"%2C"parentId"%3A""%2C"pgIdx"%3A""%2C"pgTot"%3A""%2C"anoncknm"%3A""%2C"afd"%3A""%2C"issso"%3A"0"%2C"aadState"%3A"0"}%27&-behavior=0&-market=%27en-au%27){kind=small}